Mdro infection controlnursing final version 11.17.09 1
-
Upload
capstonerx -
Category
Documents
-
view
2.524 -
download
0
description
Transcript of Mdro infection controlnursing final version 11.17.09 1
![Page 1: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/1.jpg)
MDRO (Multiple drug-resistant
organisms)
How they relate to patients in the healthcare setting
UT Southwestern University Hospitals: Infection Control Department
![Page 2: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/2.jpg)
Multi-drug resistant organisms (MDRO’s) have increased in prevalence in US hospitals over the last three decades
These organisms have important implications for patient safety
Options for treating patients with these infections are often extremely limited
MDRO infections are associated with increased lengths of stay, costs, and mortality
Background
![Page 3: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/3.jpg)
Methicillin Resistant Staphylococcus aureus (MRSA) was first isolated in the United States in 1968.
In the early 1990s, MRSA accounted for 20%-25% of Staphylococcus aureus isolates from hospitalized patients.
By 2003, MRSA accounted for >50% of S. aureus isolates from patients in ICUs.
A similar rise in prevalence has occurred with Vancomycin Resistant Enterococcus (VRE) . From 1990 to 1997, the prevalence of VRE in Enterococcus isolates from hospitalized patients increased from <1% to approximately 15% .
By 2003 VRE accounted for 28.5 % of Enterococcus isolates in ICUs.
History of MDRO’s
![Page 4: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/4.jpg)
Methicillin-Resistant Staphylococcus aureus (MRSA)
Vancomycin-Resistant Enterococcus species (VRE) Multidrug-Resistant (MDR) Acinetobacter
species. Multidrug-Resistant (MDR) Klebsiella species,
Enterobacter species, and Escherichia coli.
Resistant Organisms include:
![Page 5: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/5.jpg)
To be defined as an MDRO the organism must meet these criteria:
MRSA: S. aureus tests resistant to Oxacillin
VRE: Enterococcus species tests resistant to Vancomycin.
MDRO-Acinetobacter species: Resistant to all agents tested within at least 3 antimicrobial classes, including B-lactams, carbapenems, aminoglycosides and fluoroquinolones
Specific definitions
![Page 6: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/6.jpg)
New Resistant Bacteria
Mutations
XX
Emergence of Antimicrobial Resistance
Susceptible Bacteria
Resistant Bacteria
Resistance Gene Transfer
Bacteria have evolved to evade antimicrobial drugs through chromosomal mutations & acquisition of resistance genes via conjugation, transposition, or transformation
![Page 7: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/7.jpg)
Resistant StrainsRare
xx
Resistant Strains Dominant
Antimicrobial Exposure
xxxx
xx
xx
xx
Selection for antimicrobial-resistant Strains
Once resistant strains of bacteria are present in a population, exposure to antimicrobial drugs favors their survival.
![Page 8: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/8.jpg)
S. aureus
Penicillin
[1950s]
Penicillin-resistant
S. aureus
Methicillin
[1970s]
Methicillin-resistant S. aureus (MRSA)
Vancomycin-resistant
enterococci (VRE)
Vancomycin
[1990s]
[1997]
Vancomycin
intermediate-resistantS. aureus (VISA)
[ ???? ]Vancomycin-
resistantS. aureus
Introduction of every new class of antimicrobial drug is followed by emergence of resistance
![Page 9: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/9.jpg)
B-lactams: includes ampicillin/sulbactam, piperacillin/tazobactam, cefepime, ceftazidime
Carbapenems: includes imipenam, meropenem and doripenam
Aminoglycosides: includes amikacin, gentamycin, tobramycin
Fluoroquinolones: includes ciprofloxacin, levofloxacin
Drug classes:
![Page 10: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/10.jpg)
Staphylococcus aureus◦ commonly found on skin, in eyes, upper respiratory track, mouth, and GU system◦ developed resistance to many Antibiotics including Methicillin (oxacillin) to create the
particular strain, MRSA
MRSA ◦ Is found anywhere Staphylococcus aureus is commonly found◦ may colonize the patient or cause active infections◦ is a public health concern because there are few drugs left to treat serious MRSA
infections. Vancomycin is the current drug of choice for serious infections. Other antimicrobial agents would include: Daptomycin and Linezolid.
A high percentage of wound infections are caused by MRSA.
Reservoirs for MRSA in the hospital include infected or colonized patients with HCW being the link for nosocomial spread of the infection. The main mode of transmission is via hands of HCW.
Other reservoirs include contaminated equipment and other items in the environment
Methicillin-Resistant Staphylococcus aureus (MRSA)Fact Sheet
![Page 11: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/11.jpg)
The emergence of new epidemic strains of MRSA in the community, (CA-MRSA) among patients without established MRSA risk factors, may present new challenges to MRSA control in healthcare settings.
Historically, genetic analyses of MRSA isolated from patients in hospitals worldwide revealed a relatively small number of MRSA strains have the unique qualities to facilitate transmission from patient to patient.
To date, most MRSA strains isolated from patients with CA-MRSA
infections have been microbiologically distinct from those endemic in healthcare settings, suggesting some of these strains may have arisen de novo in the community via the acquisition of the mecA gene from Methicillin Susceptible Staph aureus.
CA-MRSA infection commonly presents as relatively minor skin and soft tissue infections, but severe invasive disease and mortalities have been described in children and adults.
Community-associated MRSA
![Page 12: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/12.jpg)
When a patient is identified as having an infection or colonization with an MDRO:
◦ Place the patient in Contact Precautions
◦ Enter the isolation information into EPIC
◦ Staff will be alerted of isolation status upon subsequent admissions into the hospital
Monitoring of MDRO’s
![Page 13: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/13.jpg)
Infection control monitors MDRO incidence and transmission and provides data monthly and quarterly to the units
Monitoring of MDRO’s
![Page 14: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/14.jpg)
Removing Patients From Isolation Follow-up screenings MUST be negative:
Original site of infection +
Nasal if previously MRSA positive or
Rectal if previously VRE positive
Once the C. Diff positive patient is discharged, the isolation is removed automatically
Notify Infection Control to Remove Isolation Status from EPIC
![Page 15: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/15.jpg)
Once MDROs are introduced into a healthcare setting, transmission and persistence of the resistant strain is determined by the:
◦ availability of vulnerable patients◦ selective pressure exerted by antimicrobial use.◦ the number of patients already colonized with an MDRO◦ the impact of implementation and adherence to prevention efforts
Patients vulnerable to colonization and infection include:
◦ those with severe disease◦ those with compromised host defenses from underlying medical conditions◦ recent surgery◦ indwelling medical devices (e.g., urinary catheters or endotracheal tubes)
Hospitalized patients have more risk factors than non-hospitalized patients, and have the highest infection rates.
![Page 16: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/16.jpg)
There is ample epidemiologic evidence to suggest MDROs are carried from one person to another via the hands of HCW.
Hands are easily contaminated during the process of care-giving or from contact with environmental surfaces in close proximity to the patient.
Without adherence to published recommendations for hand hygiene and glove use HCW are more likely to transmit MDROs to patients.
Strategies to increase and monitor adherence are important components of MDRO control programs.
Hands are the culprits
![Page 17: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/17.jpg)
Standard Precautions are a group of infection prevention practices which apply to all patients, regardless of suspected or confirmed infection status. They are in effect for all patients, all the time.
These include the use of: * Hand hygiene Gloves Gown Mask Eye protection, or face shield*depending on the anticipated exposure; and safe injection practices.
Equipment or items in the patient environment likely to have been contaminated with body fluids must be handled in a manner to prevent transmission of infectious agents.
![Page 18: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/18.jpg)
While good hand hygiene remains the most important method to prevent the transmission of any organism on the hands of HCW, the addition of Contact Precautions can break the chain of infection by preventing the organisms from being carried from one room to another on inanimate objects (foamites).
Contact Precautions
![Page 19: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/19.jpg)
Touching the PATIENT isn’t the only way to become contaminated with an MDRO!
![Page 20: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/20.jpg)
Place green Contact Isolation sign on the room door
Any PERSON entering the room wears gloves and gown, no matter the reason for entering the room or for how long. This includes all staff and visitors.
Contact Isolation Precautions
![Page 21: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/21.jpg)
Contact Isolation Precautions
Remove Personal Protective Equipment and perform hand hygiene BEFORE leaving the room.
Equipment from a Contact Precautions room should be disinfected before being used for the care of another patient .
![Page 22: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/22.jpg)
Contact Isolation Precautions Sign
Contact
Sign Color Fluorescent Green
Type of Organism Isolated
MRSA
VRE
Clostridium difficile
Lice
Scabies
Procedure for Isolation
Wash Hands
Don Gown & Gloves BEFORE entering room
REMOVE Gown & Gloves BEFORE leaving room
Wash hands-- Soap & water only if C. diff, otherwise use alcohol foam when leaving room
![Page 23: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/23.jpg)
C. difficile
Sign Color Red Stop Sign
Type of OrganismIsolated
Clostridium difficile
Procedure for Isolation
Wash Hands
Don Gown & Gloves BEFORE entering room
REMOVE Gown & Gloves BEFORE leaving room
Wash hands--SOAP & WATER ONLY when leaving roomStop Sign for Clostridium difficile
Contact Precautions+
Use ONLY soap & water to wash hands
![Page 24: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/24.jpg)
Droplet
Sign Color Fluorescent Yellow/ Orange
Type of Organism Isolated
RSV
Influenza
Meningitis
Procedure for Isolation
Wash hands
Don Surgical Mask
REMOVE Mask when leaving room
Wash Hands after leaving room with soap & water or alcohol foam
Droplet Isolation Precautions Sign
![Page 25: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/25.jpg)
Airborne
Sign Color Hot Pink
Type of Organism Isolated
AFB (Tuberculosis)
Measles
Chicken Pox
(Any staff who have NOT had measles or chicken pox or been vaccinated MAY NOT ENTER patient room.)
Procedure for Isolation
Don N95 mask BEFORE entering room
(Staff must have been fit tested by Occupational Health for appropriate size upon hire.)
Wash Hands
REMOVE Mask when leaving room
Wash Hands after leaving room with soap & water or alcohol foam
Airborne Isolation Precautions Sign
![Page 26: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/26.jpg)
12 Steps to Prevent Antimicrobial Resistance: Hospitalized Adults
12 Contain your contagion
11 Isolate the pathogen
10 Stop treatment when cured
9 Know when to say “no” to Vanco
8 Treat infection, not colonization
7 Treat infection, not contamination
6 Access the experts
5 Use local data
4 Practice antimicrobial control
3 Target the pathogen
2 Get the catheters out
1 Vaccinate
Prevent Transmission
Use Antimicrobial
s Wisely
Diagnose & Treat
Effectively
Prevent Infections
![Page 27: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/27.jpg)
Fact: Catheters and other invasive devices are the #1 exogenous cause of hospital-onset infections.
Actions:Use catheters only when essentialUse the correct catheterUse proper insertion & catheter-care
protocolsRemove catheters when not essential
Prevent Infection:Get the catheters out
![Page 28: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/28.jpg)
Antimicrobial Resistance: Key Prevention Strategies
Optimize Use
PreventTransmission
PreventInfection
EffectiveDiagnosis& Treatment
Pathogen
Antimicrobial-Resistant Pathogen
Antimicrobial Resistance
Antimicrobial Use
Infection
Susceptible Pathogen
![Page 29: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/29.jpg)
The Infection Control Team
Doramarie Arocha
Gwen Way
David Townson
![Page 30: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/30.jpg)
Fact: A major cause of antimicrobial overuse is treatment of colonization.
Actions: Treat pneumonia, not the tracheal aspirate Treat bacteremia, not the catheter tip or
hub Treat urinary tract infection, not the
indwelling catheter
Use Antimicrobials Wisely
Treat infection, not colonization
![Page 31: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/31.jpg)
Biofilm on Intravenous Catheter Connecter 24 hours after Insertion
Scanning Electron Micrograph
![Page 32: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/32.jpg)
Fact: Vancomycin overuse promotes emergence, selection, and spread of resistant pathogens.
Actions:◦ Treat infection, not contaminants or colonization ◦ Fever in a patient with an intravenous catheter is
not a routine indication for vancomycin
Know when to say “no” to vanco
![Page 33: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/33.jpg)
Fact: Failure to stop unnecessary antimicrobial treatment contributes to overuse and resistance.
Actions:When infection is curedWhen cultures are negative and
infection is unlikelyWhen infection is not diagnosed
Use Antimicrobials Wisely When to stop antimicrobial treatment
![Page 34: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/34.jpg)
Fact:Patient-to-patient spread of pathogens can be prevented. Actions:Use standard infection control
precautions Contain infectious body fluids
(use approved airborne/droplet/contact isolation precautions)
When in doubt, consult infection control experts
Prevent Transmission
![Page 35: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/35.jpg)
Fact:Healthcare personnel spread antimicrobial-resistant pathogens from patient-to-patient.
Prevent Transmission: Contain your contagion
![Page 36: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/36.jpg)
Prevent Transmission: Contain your contagion Patients from Long Term Acute Care Facilities
(LTAC) have a higher incidence of being colonized with an MDRO
Isolate immediately upon arrival, no questions asked!
Follow MDRO Reduction Protocol
Notify Infection Control
![Page 37: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/37.jpg)
Life Care◦ Dallas◦ Fort Worth◦ Plano
Vibra Specialty Hospital
Texas Specialty Hospital
Kindred Specialty Hospital◦ Multiple Locations in
Dallas and Fort Worth◦ Arlington◦ Mansfield
Gulf States LTAC Select Specialty
◦ DeSoto◦ Carrolton
Mesquite Specialty Hospital
Regency Hospital◦ Carrolton◦ Fort Worth
Plano Specialty Hospital
Baylor Specialty Hospital
Multi-Drug Resistant Organism Reduction (MDRO) Protocol: Known LTACs
![Page 38: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/38.jpg)
Multi-Drug Resistant Organism (MDRO) Reduction Screening Protocol
![Page 39: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/39.jpg)
How to Obtain a Nasal
Swab/Culture for MRSA Screen
Steps: Wash hands, apply clean gloves Peel open the BBL CultureSwab
sterile pouch at the point indicated by the diagram on the outside of the package.
Twist to remove the cap from the transport tube
Remove the swab Insert the swab approximated 2
cm (approximately ¾ inch) into the naris.
Rotate the swab against the anterior nasal mucosa for 3 seconds
Using the same swab, repeat for the other naris.
**If using swab with 2 heads, can use 1 swab for each naris.
Equipment: Clean disposable
gloves BBL CultureSwab
![Page 40: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/40.jpg)
How to Obtain a Nasal Swab/Culture for MRSA Screen--
Continued
Push the end of the swab firmly to ensure that the swab is inserted into the end of the transport tube. Ensure that the swab tip is in contact with the moistened pledget.
Secure the transport tube cap.
Label the swab with the patient’s preprinted label in the presence of the patient, in the patient’s room
Remove and discard gloves
Place in biohazard bag Transport the labeled
specimen to the lab WITHIN 1 HOUR.
Label the swab with the patient’s preprinted label in the presence of the patient, in the patient’s room
Remove and discard gloves
Place in biohazard bag Transport the labeled
specimen to the lab WITHIN 1 HOUR.
![Page 41: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/41.jpg)
Fact: Healthcare personnel spread antimicrobial-resistant pathogens from patient to patient.
Actions:Stay home when you are sick Contain your contagionKeep your hands cleanSet an example!
Prevent Transmission Break the chain of contagion
![Page 42: Mdro infection controlnursing final version 11.17.09 1](https://reader034.fdocuments.us/reader034/viewer/2022052619/55502206b4c905af648b5415/html5/thumbnails/42.jpg)